Figure 5.(A) Immunohistochemical staining demonstrates Glypican 3 positivity in the tumor cells, (Immunohistochemistry, × 400). (B) The tumor cells exhibit moderate HepPar1 expression on immunostaining, (Immunohistochemistry, × 200). (C) Tumor cells show positive immunoreactivity for CK19, (Immunohistochemistry, magnification × 400). (D) Positive immunostaining of tumor cells with CK 7, (Immunohistochemistry, × 200).
